Ligand Pharmaceuticals Incorporated
LGND · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $117 | $5 | -$42 | -$31 |
| Dep. & Amort. | $7 | $9 | $9 | $9 |
| Deferred Tax | $9 | -$0 | -$9 | -$13 |
| Stock-Based Comp. | $15 | $0 | $0 | $8 |
| Change in WC | $11 | -$6 | -$5 | $12 |
| Other Non-Cash | -$146 | $9 | $22 | $44 |
| Operating Cash Flow | $13 | $16 | -$26 | $28 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$2 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $80 |
| Inv. Purchases | -$392 | -$63 | -$59 | -$97 |
| Inv. Sales/Matur. | $53 | $51 | $71 | $45 |
| Other Inv. Act. | $4 | $2 | -$4 | -$66 |
| Investing Cash Flow | -$334 | -$11 | $5 | -$39 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$0 | -$0 | -$0 |
| Stock Issued | -$12 | $8 | $4 | $3 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$10 | $7 | -$9 | $17 |
| Financing Cash Flow | -$10 | $15 | -$5 | $20 |
| Forex Effect | $0 | -$0 | $1 | -$2 |
| Net Chg. in Cash | -$68 | $20 | -$24 | $9 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $68 | $48 | $72 | $64 |
| End Cash | $0 | $68 | $48 | $72 |
| Free Cash Flow | $13 | $16 | -$26 | $28 |